Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1425 in advanced or metastatic breast cancer
NCT01006785Phase 2Terminated
- Sponsor
- Dexa Medica
- Start
- Aug 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DLBS1425 in breast cancer, sponsored by Dexa Medica. Started Aug 2009; status: terminated.
02
Drugs
DLBS1425
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01006785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006785.